Treatment of Pulmonary Disease Due to Mycobacterium kansasii: Recent Experience with Rifampin

Records of 244 patients with Mycobacterium kansasii isolated from their sputum were reviewed. Of the 244 patients, 82 failed to meet study criteria and were excluded. Response to treatment and posttreatment follow-up was evaluated in 162 patients. Overall, 135 patients (83%) achieved negative sputum...

Full description

Saved in:

Bibliographic Details
Published in:	Reviews of infectious diseases Vol. 3; no. 5; pp. 1035 - 1039
Main Authors:	Pezzia, W, Raleigh, J W, Bailey, M C, Toth, E A, Silverblatt, J
Format:	Journal Article
Language:	English
Published:	United States University of Chicago Press 01-09-1981
Subjects:	Adult Aged Antibacterials Follow-Up Studies Fungal infections Fungal lung diseases Humans Isoniazid - pharmacology Lung diseases Male Microbial Sensitivity Tests Middle Aged Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium kansasii Nontuberculous Mycobacteria - drug effects Obstructive lung diseases Pretreatment Pulmonary tuberculosis Relapse Rifampin - therapeutic use Session VI: Clinical Aspects Sputum Sputum - microbiology Streptomycin - pharmacology Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - surgery
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!